9,307 research outputs found
Chapter 14: MD Anderson Publications and Publication Ethics
No full textDr. Goepfert has served on a number of editorial boards and is keenly interested in the educational dissemination of information critical to cancer research. In this section he talks about some of MD Anderson’s publications and also addresses some controversies with publication. He first raises the ethical issue of how authorship is assigned to a manuscript going out for publication. Today there are guidelines for assigning authorship, but twenty years ago, he explains, some department chairs at MD Anderson reviewed all manuscripts going for publication and insisted on being listed as first author of an article, whether they made any contribution to the research or not. Dr. Goepfert contrasts his own practice of putting his name on a paper only if he has contributed. Dr. Goepfert then shifts subjects and describes several MD Anderson educational publications, beginning with Cancer Bulletin, distributed free to all physicians across Texas.https://openworks.mdanderson.org/mchv_interviewchapters/2010/thumbnail.jp
Promise - Spring 2020
No full textRogers Award honors MD Anderson nursing assistant MD Anderson awards highest nursing honor Low-grade serous ovarian cancer survivor establishes research nonprofit Celebrity Chef Cooking Demo makes young cancer patients sous-chefs for a day Bob’s Encore: hope in the fight against pancreatic cancer Board of Visitors welcomes seven new members Board of Visitors awards highest distinction to longtime member A Conversation with a Living Legend raises 2 million for cancer research, education and prevention Get to know Advance Team’s Laura Nelson Cookbook author leaves her mark on gastric cancer researchhttps://openworks.mdanderson.org/promise/1001/thumbnail.jp
Chapter 09: Creating a New Way of Conducting Research and Caring for Patients in a Changing Environment
No full textIn this chapter, Dr. Dmitrovsky provides an overview of how MD Anderson must operate in the new environment of research and healthcare economics. He begins by explaining that scientific endeavors traditionally rely on decisive discoveries by individual investigators that also reveal opportunities to development treatments. Today, he says, this process moves ahead via team- and interdisciplinary science, and the institution must educate the next generations of researchers in this way of conducting research. At the same time, MD Anderson must operate in a context of a flat NIH budget while responding to the new economics of the Affordable Care Act. Next, he notes that MD Anderson is supporting the education of the next generation by making investments in junior faculty with the R. Lee Clark Fellowship Program. He explains the award (juried by experts outside of MD Anderson). Next Dr. Dmitrovsky notes that reductions are being made to the length and complexity of informed consent forms so faculty can spend less time on paperwork and more time for their primary activities. He then speaks briefly about faculty recruitment and retention efforts. Then Dr. Dmitrovsky talks about strategies used to encourage interdisciplinary investigation. He speaks in detail about finding ways to provide team members with proper recognition for their contributions (when contribution is traditionally measured by first or last author status) and linking credit to faculty promotion. He also talks about empowering team members to initiate investigations and provides some examples.https://openworks.mdanderson.org/mchv_interviewchapters/1641/thumbnail.jp
Chapter 09: Strengthening Biomedical Editing Nationwide and Within MD Anderson
No full textIn this Chapter, first briefly notes his involvement with the Southwest Chapter of the American Medical Writer’s Association and the Council of Biology Editors (with a 22-year membership). He then explains that he had his biggest impact while he served on the Board of Editors in the Life Sciences and in the late 80s worked on the Editorial Certification Examination Development Committee. He describes the examination he helped create to certify competence for editors of biomedical articles and explains the significance of certification. He notes that the Department of Scientific Publications at MD Anderson uses its own battery of tests to evaluate editors’ abilities for abstract reasoning, grammar, and other skills and talents.
Next, Mr. Pagel talks about his Department’s blog, “The Write Stuff,” and two significant projects: his role on the Historical Resources Center Steering Committee, and the development of panel discussions for the Department of Scientific Publications. To begin the discussion of the Steering Committee, he notes that Scientific Publications wrote The First Twenty Years, the first history of MD Anderson. Because of this association with the institution’s history, Mr. Pagel was asked to be part of the Steering Committee when the Historical Resources Center was formed and set as its first goal the publication of an updated institutional history. Mr. Pagel wanted the perspective to be broader than the first book, situating MD Anderson and cancer research in a larger context of other cancer institutions and the history of cancer research. Though not alone in holding this view, he says he had something to do with articulating it for the benefit of the Steering Committee. He describes how James Olsen was selected to be the author and notes other Steering Committee activities.https://openworks.mdanderson.org/mchv_interviewchapters/2275/thumbnail.jp
E. Harold Shryock, MD
No full textA teacher of the ages, administrator, author, lecturer, ambidextrous artist, trick cyclist, Chair of the Department of Anatomy, and Dean of the School of Medicine of Loma Linda University.All descriptions are taken verbatim from: Portraits of Honored Faculty by S. Wesley Kime, MD. Editor Raymond Herber, MD. (Loma Linda, Calif.: Alumni Association of School of Medicine of Loma Linda University, 2005) and are thus not up-to-date as to positions held or contributions made to Loma Linda University Health
Chapter 09: Reflections on Dr. Clifton Mountain and Data Collection Roles at MD Anderson
No full textMrs. Hermes begins this chapter with memories of how much she enjoyed working for Dr. Mountain over the course of 25 years. He taught her how to think about data, she explains, and she was listed as an author on a number of publications on lung cancer [see examples below]. She explains that Dr. Mountain left MD Anderson in 1993, but she continued to work freelance for him. She recalls that he set up the first conference on mathematics at MD Anderson, early in his career sometime in the sixties.
Next she comments on how the unique openness of Houston culture fit well with the bold visions that both R. Lee Clark and Eleanor MacDonald held for oncology. She says that her most important work was on Dr. Mountain’s staging system for lung cancer and she explains why staging the disease presented challenges.
She confirms that she was always interested in the implications of basic research for clinical findings. She credits Eleanor MacDonald for helping her to develop her curiosity and questioning style.https://openworks.mdanderson.org/mchv_interviewchapters/2036/thumbnail.jp
Communicating Chemical Congregation: A Molecular AND Logic Gate with Three Chemical Inputs as a �Lab-on-a-Molecule� Prototype
No full textPT: J; CR: ABBOTT EA, 1950, FLATLAND ROMANCE MAN AMENDOLA V, 2001, ACCOUNTS CHEM RES, V34, P488 BADJIC JD, 2004, SCIENCE, V303, P1845 BAG B, 2005, CHEM COMMUN 0128, P513 BALZANI V, 2003, MOL DEVICES MACHINES BHATTACHARYA S, 2003, CHEM COMMUN, P1158 BISSELL RA, 1992, J CHEM SOC P2, P1559 CALLAN JF, 2004, CHEM COMMUN, P2048 CHANG CJ, 2004, CHEM BIOL, V11, P203 DESILVA AP, 1993, NATURE, V364, P42 DESILVA AP, 1997, CHEM REV, V97, P1515 DESILVA AP, 1997, J AM CHEM SOC, V119, P7891 DESILVA AP, 1999, J AM CHEM SOC, V121, P1393 DESILVA AP, 2001, ELECT TRANSFER CHEM, V5, P156 DESILVA AP, 2001, MOL SWITCHES, P339 DESILVA AP, 2004, CHEM-EUR J, V10, P574 DESILVA SA, 2002, CHEM COMMUN, P1360 FABBRIZZI L, 1999, ACCOUNTS CHEM RES, V32, P846 FARINAS J, 1999, J BIOL CHEM, V274, P7603 GUNNLAUGSSON T, 2003, ORG BIOMOL CHEM, V1, P3265 GUNNLAUGSSON T, 2003, ORG LETT, V5, P4065 GUNNLAUGSSON T, 2004, TETRAHEDRON, V60, P11239 GUO XF, 2004, ADV MATER, V16, P125 HE HR, 2003, ANAL CHEM, V75, P549 HE HR, 2003, J AM CHEM SOC, V125, P1468 HERNANDEZ JV, 2004, SCIENCE, V306, P1532 HIRSCH ED, 2002, NEW DICT CULTURAL LI IZATT RM, 1976, J AM CHEM SOC, V98, P7626 IZATT RM, 1985, CHEM REV, V85, P271 KOSKELA SJM, 2004, CHEM COMMUN, P945 LANKSHEAR MD, 2006, CHEM COMMUN 0214, P612 LIM NC, 2004, CHEM COMMUN 0507, P1094 MARGULIES D, 2004, J AM CHEM SOC, V126, P15400 MARGULIES D, 2005, NAT MATER, V4, P768 MILLMAN J, 1988, MICROELECTRONICS NICOLL D, 2004, DIAGNOSTIC TESTS RAYMO FM, 2002, ADV MATER, V14, P401 SAUVAGE JP, 1998, ACCOUNTS CHEM RES, V31, P611 SMITH RM, 1974, CRITICAL STABILITY C STOJANOVIC MN, 2003, NAT BIOTECHNOL, V21, P1069 TSIEN RY, 1992, AM J PHYSIOL, V263, C723 TUSA JK, 2005, J MATER CHEM, V15, P2640 UCHIYAMA S, 2004, J AM CHEM SOC, V126, P3032 UCHIYAMA S, 2005, J AM CHEM SOC, V127, P8920 WANG HM, 2004, CHEM COMMUN 0321, P670 WISKUR SL, 2001, ACCOUNTS CHEM RES, V34, P963 WOODROOFE CC, 2003, J AM CHEM SOC, V125, P11458; NR: 47; TC: 10; J9: J AM CHEM SOC; PG: 2; GA: 034GNSource type: Electronic(1
Library News December 2025
No full textReducing Barriers to Learning: MD Anderson\u27s OER Initiative How to Navigate Author Instructions (part 1) Best and Worst Books of 2025 A Noteworthy Article about Notable, Noteworthy, and Noticeablehttps://openworks.mdanderson.org/rmlnews25/1011/thumbnail.jp
Joel Glaser, MD: A Scholar\u27s Scholar
No full textJoel Glaser, MD is considered one of the great scholars of neuro-ophthalmology. His published contributions touch nearly every aspect of the field. The principal author of the highly respected textbook Neuro-Ophthalmology, he has trained over 50 fellows who occupy important academic positions across the planet.curriculum_fellow; IC-H1-history-of-neuro-ophthalmolog
Supplemental Data for A Phase II Study of Talazoparib Tosylate in Advanced Cancer Patients with Somatic and Germline (Not Breast or Ovarian Cancer) Alterations of BRCA1/2, Mutations/Deletions/Amplification in Other Homologous Recombination Repair Pathway Genes and PTEN or PTEN loss
No full textThe de-identified participant data and dataset generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Custom code that was used in the generation or analysis of the datasets is available upon reasonable request.
Corresponding Author: Sarina Piha-Paul,Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX. Phone: (713)-563-1055, Fax:(713)-792-3535, [email protected]://openworks.mdanderson.org/ict/1000/thumbnail.jp
- …
